Afatinib, an EGFR/Her-2 dual inhibitor, effectively radiosensitizes bladder cancer cells

被引：0
|
作者：
Tsai, Yu-Chieh [1 ]
Chen, Jason Chia-Hsien [1 ]
Tuan, Tsung-Fan [1 ]
Yeh, Chih-Hsien [1 ]
Ho, Pei-Yin [2 ]
Pu, Yeong-Shiau [1 ]
Cheng, Ann-Lii [1 ]
机构：
[1] Natl Taiwan Univ Hosp, Taipei, Taiwan
[2] Natl Taiwan Univ, Taipei 10764, Taiwan
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/1538-7445.AM2012-1464
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1464
引用
收藏
页数：2
相关论文
共 50 条
  • [31] The dual EGFR/HER-2 kinase inhibitor lapatinib induces apoptosis and potentiates anti-IGF-IR therapy in trastuzumab-resistant breast cancer cells
    Nahta, Rita
    Yuan, Linda Xh
    Esteva, Francisco J.
    CANCER RESEARCH, 2006, 66 (08)
  • [32] Antiproliferative effect in human breast cancer cells with the combination of a sheddase inhibitor and a dual EGFR-HER-2/neu inhibitor.
    Witters, L. M.
    Scherle, P. A.
    Friedman, S. M.
    Lipton, A.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S208 - S208
  • [33] MicroRNA-200c radiosensitizes Human Cancer Cells with Activated EGFR or HER2-associated Signaling
    Kim, I. A.
    Koo, T.
    Cho, B.
    Choi, E.
    Lee, D.
    Kim, H.
    Kim, D.
    Park, J.
    RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S199 - S200
  • [34] Delphinidin dietary anthocyanidin modulates EGFR/HER-2 signaling pathway in breast cancer cells
    Afaq, Farrukh
    Khan, Naghma
    Mukhtar, Hasan
    CANCER RESEARCH, 2011, 71
  • [35] Lapatinib prevents metastatic colonization of EGFR and Her-2 overexpressing breast cancer cells in the brain
    Gril, Brunilde
    Palmieri, Diane
    Hua, Emily K.
    Vega-Valle, Eleazar
    Herring, Jeanne
    Feigenbaum, Lionel
    Liewehr, David J.
    Steinberg, Seth M.
    Rubin, Stephen D.
    Steeg, Patricia S.
    CLINICAL & EXPERIMENTAL METASTASIS, 2009, 26 (07) : 880 - 880
  • [36] INHIBITION OF EGFR/HER-2 AFFECTS GROWTH OF ASCITIC OVARIAN CANCER CELLS IN VITRO STUDY
    Chitcholtan, K.
    Evans, J.
    Sykes, P.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 249 - 249
  • [37] Expression of EGFR, HER-2 and p53 predictive of prognosis in muscle-invasive bladder cancer
    Sakr, W.
    Marur, S.
    Che, M.
    Heilbrun, L.
    Smith, D.
    Powell, I.
    Pontes, E.
    Cher, M.
    Vaishampayan, U.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [38] Synergistic Blockade of EGFR and HER2 by New-Generation EGFR Tyrosine Kinase Inhibitor Enhances Radiation Effect in Bladder Cancer Cells
    Tsai, Yu-Chieh
    Ho, Pei-Yin
    Tzen, Kai-Yuan
    Tuan, Tsung-Fan
    Liu, Wei-Lin
    Cheng, Ann-Lii
    Pu, Yeong-Shiau
    Cheng, Jason Chia-Hsien
    MOLECULAR CANCER THERAPEUTICS, 2015, 14 (03) : 810 - 820
  • [39] HER-2 and TOP2A coamplification in urinary bladder cancer
    Simon, R
    Atefy, R
    Wagner, U
    Forster, T
    Fijan, A
    Bruderer, J
    Wilber, K
    Mihatsch, MJ
    Gasser, T
    Sauter, G
    INTERNATIONAL JOURNAL OF CANCER, 2003, 107 (05) : 764 - 772
  • [40] HER-2 and TOP2A amplifications in urinary bladder cancer
    Simon, R
    Atefy, R
    Wagner, U
    Forster, T
    Fijan, A
    Bruderer, J
    Wilber, K
    Mihatsch, MJ
    Gasser, T
    Sauter, G
    PATHOLOGY OF THE KIDNEYS AND URINARY PASSAGES - MOLECULAR VASCULAR PATHOLOGY AND ANGIOGENESIS, 2002, 86 : 176 - 183
12345